Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 10;20(1):146.
doi: 10.1186/s12931-019-1110-2.

Effects of use of an eHealth platform e-Vita for COPD patients on disease specific quality of life domains

Affiliations

Effects of use of an eHealth platform e-Vita for COPD patients on disease specific quality of life domains

Esther P W A Talboom-Kamp et al. Respir Res. .

Abstract

Background: Integrated disease management with self-management for Chronic Obstructive Pulmonary Disease (COPD) is effective to improve clinical outcomes. eHealth can improve patients' involvement to be able to accept and maintain a healthier lifestyle. Eventhough there is mixed evidence of the impact of eHealth on quality of life (QoL) in different settings.

Aim: The primary aim of the e-Vita-COPD-study was to investigate the effect of use of eHealth patient platforms on disease specific QoL of COPD patients.

Methods: We evaluated the impact of an eHealth platform on disease specific QoL measured with the clinical COPD questionnaire (CCQ), including subscales of symptoms, functional state and mental state. Interrupted time series (ITS) design was used to collect CCQ data at multiple time points. Multilevel linear regression modelling was used to compare trends in CCQ before and after the intervention.

Results: Of 742 invited COPD patients, 244 signed informed consent. For the analyses, we only included patients who actually used the eHealth platform (n = 123). The decrease of CCQ-symptoms was 0.20% before the intervention and 0.27% after the intervention; this difference in slopes was statistically significant (P = 0.027). The decrease of CCQ-mental was 0.97% before the intervention and after the intervention there was an increase of 0.017%; this difference was statistically significant (P = 0.01). No significant difference was found in the slopes of CCQ (P = 0.12) and CCQ-function (P = 0.11) before and after the intervention.

Conclusion: The e-Vita eHealth platform had a potential beneficial impact on the CCQ-symptoms of COPD patients, but not on functional state. The CCQ-mental state remained stable after the intervention, but this was a deterioration compared to the improving situation before the start of the eHealth platform. Therefore, health care providers should be aware that, although symptoms improve, there might be a slight increase in anxiety and depression after introducing an eHealth intervention to support self-management.

Trial registration: Our study is registered in the Dutch Trial Register (national registration of clinical trails, mandatory for publication) with number NTR4098 and can be found at http://www.trialregister.nl/trial/3936 . Date registered: 2013-07-31. First participant: 2014-01-01.

PubMed Disclaimer

Conflict of interest statement

The authors declares that they have no competing interests.

Figures

Fig. 1
Fig. 1
Usage patterns in each group
Fig. 2
Fig. 2
a Total group analysis of CCQ, b total group analysis of CCQ-functional state, c total group analysis of CCQ-mental state, d total group analysis of CCQ-symptoms
Fig. 3
Fig. 3
Attrition

References

    1. Epping-Jordan J, Bengoa R, Kawar R, et al. The challenge of chronic conditions: WHO responds. BMJ. 2001;323(7319):947–948. doi: 10.1136/bmj.323.7319.947. - DOI - PMC - PubMed
    1. Boriani G, Diemberger I, Ziacchi M, et al. AF burden is important - fact or fiction? Int J Clin Pract. 2014;68(4):444–452. doi: 10.1111/ijcp.12326. - DOI - PubMed
    1. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA. 2001;285(18):2370–2375. doi: 10.1001/jama.285.18.2370. - DOI - PubMed
    1. Heit JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost. 2005;3(8):1611–1617. doi: 10.1111/j.1538-7836.2005.01415.x. - DOI - PubMed
    1. Lopez-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. doi: 10.1111/resp.12660. - DOI - PubMed